Sector Gamma As as of Dec. 31, 2019
Portfolio Holdings for Sector Gamma As
Sector Gamma As holds 37 positions in its portfolio as reported in the December 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Bristol Myers Squibb (BMY) | 9.9 | $62M | 965k | 64.19 | |
| Abbott Laboratories (ABT) | 7.9 | $49M | 566k | 86.86 | |
| Boston Scientific Corporation (BSX) | 7.5 | $47M | 1.0M | 45.22 | |
| Merck & Co (MRK) | 5.2 | $32M | 355k | 90.95 | |
| Biogen Idec (BIIB) | 4.9 | $30M | 102k | 296.73 | |
| NuVasive | 4.8 | $30M | 388k | 77.34 | |
| PerkinElmer (RVTY) | 4.8 | $30M | 308k | 97.10 | |
| Gilead Sciences (GILD) | 4.3 | $27M | 416k | 64.98 | |
| Incyte Corporation (INCY) | 4.0 | $25M | 283k | 87.32 | |
| Agilent Technologies Inc C ommon (A) | 3.8 | $24M | 278k | 85.31 | |
| Anthem (ELV) | 3.7 | $23M | 77k | 302.03 | |
| Bruker Corporation (BRKR) | 2.8 | $17M | 342k | 50.97 | |
| Johnson & Johnson (JNJ) | 2.7 | $17M | 117k | 145.87 | |
| Humana (HUM) | 2.7 | $17M | 45k | 366.52 | |
| Bio-Rad Laboratories (BIO) | 2.7 | $17M | 45k | 370.02 | |
| Qiagen Nv | 2.4 | $15M | 434k | 33.80 | |
| Perrigo Company (PRGO) | 2.3 | $14M | 273k | 51.66 | |
| Alexion Pharmaceuticals | 2.2 | $14M | 126k | 108.15 | |
| United Therapeutics Corporation (UTHR) | 2.1 | $13M | 151k | 88.08 | |
| Ionis Pharmaceuticals (IONS) | 2.1 | $13M | 218k | 60.41 | |
| Elanco Animal Health (ELAN) | 2.0 | $13M | 434k | 29.45 | |
| Cardinal Health (CAH) | 1.7 | $11M | 213k | 50.58 | |
| Regeneron Pharmaceuticals (REGN) | 1.7 | $11M | 29k | 375.47 | |
| Patterson Companies (PDCO) | 1.6 | $9.8M | 477k | 20.48 | |
| Universal Health Services (UHS) | 1.5 | $9.4M | 66k | 143.46 | |
| Ultragenyx Pharmaceutical (RARE) | 1.5 | $9.2M | 215k | 42.71 | |
| Quest Diagnostics Incorporated (DGX) | 1.3 | $8.2M | 77k | 106.79 | |
| Tenet Healthcare Corporation (THC) | 1.0 | $6.5M | 171k | 38.03 | |
| BioMarin Pharmaceutical (BMRN) | 1.0 | $6.3M | 75k | 84.55 | |
| Bluebird Bio (BLUE) | 0.9 | $5.5M | 62k | 87.76 | |
| Ptc Therapeutics I (PTCT) | 0.8 | $4.8M | 100k | 48.03 | |
| Clovis Oncology | 0.7 | $4.3M | 409k | 10.43 | |
| Portola Pharmaceuticals | 0.5 | $3.1M | 131k | 23.88 | |
| Agios Pharmaceuticals (AGIO) | 0.5 | $3.1M | 64k | 47.75 | |
| Eli Lilly & Co. (LLY) | 0.3 | $2.0M | 16k | 131.41 | |
| Sangamo Biosciences (SGMO) | 0.3 | $1.8M | 212k | 8.37 | |
| Takeda Pharmaceutical (TAK) | 0.1 | $609k | 31k | 19.73 |
